Fosun Pharmaceutical Extends Deadline of 81 Million Yuan Shareholder Loans to Fuyun Health; Shares Up 7%
MT Newswires Live
Sep 07
Shanghai Fosun Pharmaceutical (HKG:2196, SHA:600196), along with its controlling shareholder and subsidiaries, agreed to extend the shareholder loans worth 80.8 million yuan provided to Fuyun Health for another year, according to a Shanghai bourse filing over the weekend.
The Chinese pharmaceutical company's Hong Kong shares jumped 7%, while Shanghai shares rose 1% during Monday's midday trade.
The loans' extended maturity date will be Sept. 4, 2027, and the annual interest rate during the extension period will remain at 3.2%.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.